B. Lutzke

发表

Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.

Thomas J. Raub, E. Hall, D. Ayer, 1996, Acta neurochirurgica. Supplement.

Purification of an Endogenous Digitalislike Factor From Human Plasma for Structural Analysis

M. A. Clark, W. Mathews, F. Mandel, 1991, Hypertension.

Quantification of gemcitabine incorporation into human DNA by LC/MS/MS as a surrogate measure for target engagement.

B. Ackermann, S. Pratt, G. Schultz, 2010, Analytical chemistry.

An improved method for the identification and quantitation of biological lipids by HPLC using laser light-scattering detection.

J. Braughler, B. Lutzke, 1990, Journal of lipid research.

Kinetic evaluation of lipophilic inhibitors of lipid peroxidation in DLPC liposomes.

D. Epps, J. Mccall, B. Lutzke, 1994, Free radical biology & medicine.

Spontaneous Aggregation and Cytotoxicity of the β-Amyloid Aβ1–40: A Kinetic Model

D. Epps, R. Poorman, T. Kawabe, 2003 .

Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.

E. Hall, J. Palmer, G. Sawada, 1997, The Journal of pharmacology and experimental therapeutics.

The development of methodology for clinical measurement of 5-lipoxygenase pathway intermediates from human peripheral blood mononuclear cells.

G. Stavrakis, Robert J. White, R. Lelacheur, 2008, Journal of pharmaceutical and biomedical analysis.

Effects of the lazaroid, tirilazad mesylate, on sepsis-induced acute lung injury in minipigs.

T. Raffin, J. Mccall, M. Nakayama, 1998, Critical care medicine.

(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.

R. Lahti, M. Smith, S A Rees, 1996, Journal of medicinal chemistry.

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.

M. Piercey, R. Mccall, K. Merchant, 1996, The Journal of pharmacology and experimental therapeutics.

HPLC-chemiluminescence and thermospray LC/MS study of hydroperoxides generated from phosphatidylcholine.

E. Hall, B. Lutzke, J. Zhang, 1995, Free radical biology & medicine.

Reply to Dr. Yamamoto

B. Lutzke, Jue-Rong Zhang, E. Hall, 1995 .

Tirilazad mesylate protects stored erythrocytes against osmotic fragility.

D. Epps, J. Mccall, W. Mathews, 1994, Chemistry and physics of lipids.

Early Preclinical Evaluation of Brain Exposure in Support of Hit Identification and Lead Optimization

Geri A. Sawada, Thomas J. Raub, Barry S. Lutzke, 2006 .

Novel, highly lipophilic antioxidants readily diffuse across the blood-brain barrier and access intracellular sites.

G. Sawada, T. Raub, L. Williams, 1999, The Journal of pharmacology and experimental therapeutics.

Increased lipophilicity and subsequent cell partitioning decrease passive transcellular diffusion of novel, highly lipophilic antioxidants.

Thomas J. Raub, M. E. Houghton, N. Ho, 1999, The Journal of pharmacology and experimental therapeutics.

A validated LC-MS/MS method for neurotransmitter metabolite analysis in human cerebrospinal fluid using benzoyl chloride derivatization.

B. Ackermann, K. Svensson, Barry Jones, 2015, Bioanalysis.

Spontaneous aggregation and cytotoxicity of the beta-amyloid Abeta1-40: a kinetic model.

D. Epps, R. Poorman, T. Kawabe, 2003, Journal of protein chemistry.